Dr. Daniel P. Ferris's lab at the University of Florida focuses on improving balance training to prevent falls, particularly in older adults and individuals with neurological conditions. They study the effects of visual perturbations, such as briefly taking away visual input during balance exercises, to see how it can aid in retraining the brain's balance systems. The ultimate goal is to identify effective methods for enhancing balance, which can lead to better outcomes for those at risk of falling.

Dr. Parisa Rashidi's lab focuses on improving patient care in intensive care units by developing advanced technology for monitoring delirium, a common and serious condition in hospitalized patients. The lab is creating a system called ADAPT that uses sophisticated algorithms and sensors to track patients' mobility and sleep patterns, helping healthcare providers intervene effectively. The research aims to enhance clinical decision-making and ultimately improve patient outcomes in critical care.

Mingzhou Ding's lab at the University of Florida focuses on developing advanced AI technologies to generate and understand emotional images. Their research aims to combine artificial intelligence with neuroscience to improve how we study and treat psychiatric disorders related to emotions. This multidisciplinary work has the potential to significantly impact both the scientific community and clinical practices by providing high-quality emotional stimuli and insights into brain responses.

Dr. Benjamin Keselowsky's lab focuses on developing advanced enzyme therapies to treat psoriasis, a chronic inflammatory skin condition. The lab studies both tissue-anchored and circulating forms of these enzymes to understand how they can effectively reduce inflammation and restore metabolic balance in immune cells. By innovatively engineering these therapeutic proteins, the lab seeks to bring new solutions to patients suffering from autoimmune diseases.

Dr. Gregory Hudalla's lab focuses on developing new therapies to reduce inflammation in the body. The research aims to create synthetic assemblies of proteins that can effectively target and treat chronic inflammatory conditions without the side effects associated with traditional drugs. By engineering these protein assemblies, the lab hopes to improve how the immune system regulates inflammation, potentially aiding millions of people suffering from chronic inflammatory diseases.

Dr. Kyle D. Allen's lab at the University of Florida focuses on understanding and treating knee osteoarthritis (OA) and chronic joint pain, particularly in the knee and temporomandibular joint (TMJ). They are developing innovative approaches to deliver a special enzyme directly into the joints to reduce inflammation and improve joint health. The lab combines techniques from engineering and biology to study how nerves interact with joint tissues and how these interactions can affect pain and disability.

Dr. Ivana Parker's lab at the University of Florida focuses on understanding how bacterial vaginosis (BV) affects immune cells, specifically macrophages, and increases the risk of HIV in women. Her research combines advanced techniques like multi-omics and machine learning to analyze vaginal microbiomes and their influence on inflammation. This innovative work aims to reveal new insights into HIV prevention and women's health.

Dr. Edward Phelps' lab focuses on understanding the mechanisms behind type 1 diabetes (T1D) by studying how metabolism and immune system interactions contribute to the impairment of insulin-producing beta cells. The research uses advanced techniques on human pancreas slices to map changes in glucose metabolism and evaluate how the immune environment affects cell function. This work aims to uncover insights that could lead to new therapeutic approaches for T1D and pre-diabetes.